Free shipping on orders over $500 throughout NSW and to all interstate Capitals.
Currency
Toggle Nav
Gynaecological Cancers
Regular Price
$220.95
Special Price
$198.85
$180.77
This book provides comprehensive coverage of gynaecological malignancies based on the 60th RCOG Study Group.
Stock Status:
Out of stock
Availability:
Out of stock
SKU
9781906985448
Gynaecological cancers are categorised as 'rare' diseases, although collectively they affect over 16,000 women each year in the UK alone. There is a lack of real understanding of these conditions compared with other malignancies, possibly owing to their relative rarity when viewed as individual diseases. The 60th RCOG Study Group brought together a range of experts to examine as many biological aspects of gynaecological cancers as possible, including both surgical and non-surgical therapies. This book presents the findings of the Study Group, with contents including:• current understanding of the biology of gynaecological cancers• translation of biology to the clinic• state of the art in imaging and therapy• current clinical trials• advances in multimodal therapy• individualised treatment.
| Author | Edited by Sean Kehoe , Richard J. Edmondson , Martin Gore , Iain A. McNeish |
|---|---|
| Table Of Content | Part I. Biology of Gynaecological Cancers: Our Current Understanding: 1. Morphological sub-types of ovarian carcinoma: new developments and pathogenesis W. Glenn McCluggage 2. Novel treatment strategies for targeting genetic changes in endometrial cancer Susana Banerjee 3. Epigenetic biomarkers in ovarian cancer Robert Brown and Janet Graham 4. Predictive biology of ovarian cancer Christine A. Parkinson and James D. Brenton Part II. The Translation of Biology to the Clinic: 5. Biology of BRCA1 and BRCA2 genes and implications for cancer management Timothy A. Yap, Yvette Drew and Susan Shanley 6. Implications of homologous recombination defectiveness in ovarian cancer Richard J. Edmondson, Asima Mukhopadhyay, Aiste Cerbinskaite and Nicola J. Curtin 7. The future of PARP inhibitors in the treatment of cancer Yvette Drew, Timothy A. Yap and Stan B. Kaye Part III. Imaging and Therapy: State of the Art: 8. The role of robotics and the future Tim Mould 9. 'Ultra-radical' surgery in advanced ovarian cancer Oliver Zivanovic and Dennis S. Chi 10. Antivascular therapy in gynaecological cancers Leena Mukherjee and Gordon Rustin 11. Oncolytic viral gene therapy in ovarian cancer Iain A. McNeish 12. Endometrial cancer: what have the clinical trials taught us? Andrew Clamp 13. Targeting therapies in cancer: opportunities in ovarian cancer Ahmed Ashour Ahmed, Stefan Knapp, Anil K. Sood and Robert C. Bast Jr 14. Functional imaging: from tumour biology to the clinic Nandita M. deSouza, Evis Sala, Stavroula Kyriazi and Andrea Rockall Part IV. What Questions Are Being Asked by Current Clinical Trials?: 15. Current clinical trials in ovarian cancer Christina Fotopoulou, Angus McIndoe, Jalid Sehouli and Hani Gabra 16. Clinical trials in cervical cancer Karen Tipples and Melanie Powell 17. Clinical trials in vulval cancer Tito Lopes Part V. Consensus Views: 18. Consensus views arising from the 60th Study Group: Gynaecological Cancers: Biology and Therapeutics Index. |
| Format | Paperback |
| Publish Date | 1 Jun 2011 |
Write Your Own Review